International journal of Nano Scientific Networks and Nanotechnology (IJNN) is a multidisciplinary, peer reviewed journal which includes all the major fields in nanotechnology and Nano science. Nanoscience and nanotechnology brought up an unprecedented excitement in the scientific and engineering communities, especially the last decade. It is the engineering of functional systems at the molecular scale. This covers both current work and concepts that are more advanced.  International journal of Nano Scientific Networks and Nanotechnology   publishes original research papers during a broad area of nanoscience & engineering. IJNN provides an ideal forum for presenting original reports of theoretical and experimental nanoscience and nanotechnology research. Nanotechnology is a gathering of rising innovations in which the structure of matter is controlled at the nanometer scale, the size of little quantities of molecules, to create novel materials and gadgets that have valuable and one of kind properties. IJNN is naturally multidisciplinary, and welcomes submissions across biological, physical, engineering, and computer sciences. Contributions from both academia and industry are equally encouraged. IJNN also publishes innovative techniques and instrumentation for the fabrication, characterization and testing of nano-enabled devices and technologies, as well as advanced modelling and simulation methods.




David Lucio

PostDoctoral Research Scientist

Dr. David Lucio, 33 years old, is a PostDoctoral Research Scientist working in the Laboratory of Cancer Biotherapy of the West China School of Medicine (Sichuan University, Chengdu, China). Graduated in Chemistry by University of Burgos (Spain), with Master in Chemistry Applied to Industry and Research by University of Navarra (Spain) and PhD in Chemistry with dissertation title "Nanoparticles for the oral administration of glibenclamide" by University of Navarra (Spain). I was lecturer of Analytical Techniques during 4 years at University of Navarra (Pharmacy and Biochemistry degrees).

On research, I have been working on new strategies to improve the oral administration of different drugs (diflunisal, paclitaxel, glibenclamide...) using inclusion complexation with cyclodextrins, formation of solid dispersions with chitosans, nanoparticles with proetins and polymers, etc. Actually, I work in the field of cancer immunotherapy via dendritic cells by administering antigens encapsulated into PLGA-based nanoparticles.

I have participated in the Marie Curie International Research Staff Exchange Scheme. FP7-PEOPLE-2011-IRSES/295218. I stayed at National Engineering Research Centre of Biomaterials, Sichuan University (Chengdu. China).Research project: Targeted Delivery for Liver Cancer Treatment. I have also participated in the project of the Spanish Ministry of Science and Innovation (Program: “Retos de la Sociedad"). Thermoplastics nanocomposites antimicrobial materials with potential applications in the food industry (MAT2014-59116-C2-2-R) and the project 11963 and 11106 of the Julich Centre for Neutron Sciences founded by European Union.



Current Research

  • Polymeric nanoparticles to administer cancer immunotherapy via dendritic cells.
  • Development and characterization of new drug delivery systems.

Interested topics

  • Cancer Immunotherapy.
  • Drug/Immunotherapy Delivery Systems.
  • Internal Structure of Nanoparticles for drug/immunotherapy delivery systems
  • Prof. ZhongweiGu (National Engineering Research Centre of Biomaterials, Sichuan University, Chengdu. China) – Development of new polymers for drug delivery - 2015.
  • Prof. James Tang (Research institute in Health Care Sciences, University of Wolverhampton, Wolverhampton, United Kingdom) - Marie Curie International Research Staff Exchange Scheme. FP7-PEOPLE-2011-IRSES/295218 – 2015.
  • Dr. AurelRadulescu (Julich Centre for Neutron Sciences, Münich, Germany) – Application of Small Angle neutron Scattering to deep in the internal structure of nanoparticles – 2017.
  • Editor Board Member of EC Pharmacology and Toxicology. E-Cronicon open Access Ed.
  • Editor Board Member of International Journal of Pharma and Drug Development. Acta Scientific Ed.
Share on facebook Share on twitter Share on linkedin Share on reddit Share on mail
Whatsapp Icon